| scholarly article | Q13442814 |
| P2093 | author name string | Donald Campbell | |
| Margaret Lashof-Sullivan | |||
| Mark Holland | |||
| Erin Lavik | |||
| Rebecca Groynom | |||
| Andrew Shoffstall | |||
| P2860 | cites work | Intravenously administered nanoparticles increase survival following blast trauma | Q30584438 |
| Novel platelet substitutes: disk-shaped biodegradable nanosheets and their enhanced effects on platelet aggregation | Q33386421 | ||
| Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits | Q33504864 | ||
| Death on the battlefield (2001-2011): implications for the future of combat casualty care | Q34314250 | ||
| A profile of combat injury | Q35136408 | ||
| Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions | Q35597837 | ||
| Uses of recombinant factor VIIa in trauma | Q35992426 | ||
| Treating traumatic bleeding in a combat setting. | Q36009730 | ||
| The effect of particle size on the biodistribution of low-modulus hydrogel PRINT particles | Q36157393 | ||
| Poly(lactide) stereocomplexes: formation, structure, properties, degradation, and applications. | Q36183866 | ||
| Use of recombinant factor VIIa for adjunctive hemorrhage control in trauma and surgical patients | Q36392070 | ||
| Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations | Q36501096 | ||
| Factor VIIa (recombinant) for acute traumatic hemorrhage | Q37247512 | ||
| Current evidence based guidelines for factor VIIa use in trauma: the good, the bad, and the ugly. | Q37355232 | ||
| Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities | Q38065891 | ||
| Tranexamic acid in remote damage control resuscitation | Q38072766 | ||
| Intravenous hemostats: challenges in translation to patients | Q38148673 | ||
| Ultrasoft microgels displaying emergent platelet-like behaviours. | Q39133739 | ||
| Use of recombinant factor VILa in Operation Iraqi Freedom and Operation Enduring Freedom: survey of Army surgeons | Q40021858 | ||
| Fibrin sealant foam sprayed directly on liver injuries decreases blood loss in resuscitated rats | Q40750768 | ||
| Intravenous hemostatic nanoparticles increase survival following blunt trauma injury | Q41215308 | ||
| Intravenous hemostat: nanotechnology to halt bleeding. | Q41470605 | ||
| Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma | Q42579276 | ||
| First example of N-heterocyclic carbenes as catalysts for living polymerization: organocatalytic ring-opening polymerization of cyclic esters | Q43877992 | ||
| Thrombosomes: a platelet-derived hemostatic agent for control of noncompressible hemorrhage. | Q45902625 | ||
| Lethal injuries and time to death in a level I trauma center | Q46087296 | ||
| Stereocomplex block copolymer micelles: core-shell nanostructures with enhanced stability | Q46407621 | ||
| The effects of protocolized use of recombinant factor VIIa within a massive transfusion protocol in a civilian level I trauma center. | Q46637436 | ||
| Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. | Q50758503 | ||
| Thermal stability of prehospital medications | Q57260576 | ||
| The global burden of injuries | Q58024276 | ||
| Efficacy of FDA-approved hemostatic drugs to improve survival and reduce bleeding in rat models of uncontrolled hemorrhage | Q83937026 | ||
| P433 | issue | 3 | |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 385-392 | |
| P577 | publication date | 2016-01-18 | |
| P1433 | published in | ACS biomaterials science & engineering | Q27726392 |
| P1476 | title | Hemostatic Nanoparticles Improve Survival Following Blunt Trauma Even after 1 Week Incubation at 50 °C. | |
| P478 | volume | 2 |
Search more.